---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-203902"
form_type: "8-K"
ticker: "FBRX"
cik: "0001419041"
company_name: "Forte Biosciences, Inc."
filed_at: "2023-08-04T23:59:59+00:00"
generated_at: "2026-06-12T05:50:49.584737+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Auditor Mayer Hoffman McCann declines reappointment; FY2022 tax-provision controls deemed ineffective

## Summary
- MHM will not stand for re-appointment for FY2024; will cease by new auditor appointment, filing of 2023 10-K, or April 1, 2024.
- No disagreements between company and MHM on accounting principles or audit scope for FY2021 and FY2022.
- Reportable event: management concluded ineffective controls over completeness and accuracy of annual tax provision in FY2022 10-K.
- Audit committee will initiate process to select a new independent registered public accounting firm.
- MHM’s audit reports for FY2021 and FY2022 were unqualified, with no adverse opinion or disclaimer.

## SEC filing metadata
- accession: 0001193125-23-203902
- form_type: 8-K
- ticker: FBRX
- cik: 0001419041
- company_name: Forte Biosciences, Inc.
- filed_at: 2023-08-04T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419041/000119312523203902/0001193125-23-203902-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419041/000119312523203902/d416994d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-203902
- JSON: https://secwatch.observer/filing/0001193125-23-203902.json
- Plain text: https://secwatch.observer/filing/0001193125-23-203902.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.